Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_assertion description "[PEG-IFN-alpha 2b and ribavirin is a potentially useful therapy in HIV/HCV-co-infected patients who have failed standard IFN-based regimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_assertion evidence source_evidence_literature NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_assertion SIO_000772 15090832 NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_assertion wasDerivedFrom befree-2016 NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_assertion wasGeneratedBy ECO_0000203 NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.
- befree-2016 importedOn "2016-02-19" NP440395.RAXj6sP9G53gLTHdxgqfWQi06562WS7rDeRp0l8GsImr8130_provenance.